Relates to prescription labels for mifepristone and misoprostol

Introduced

In Committee

Floor

Crossed Over

Passed

Enacted

Overview Bill text 1 History 3 Sponsors

Mar 10, 2025 · Senate

SUBSTITUTED BY A5285

Mar 4, 2025 · Senate

ORDERED TO THIRD READING CAL.447

Feb 7, 2025 · Senate

REFERRED TO RULES

PASSAGE PROBABILITY

1% Unlikely

Why this number

Stage base In Committee — base rate 5%, measured from NY's completed sessions
Momentum -5 29/100 from the pace of recorded action
Time since last action -22 581 days quiet

A transparent scoring model over stage, momentum, recency, sponsorship and recorded votes — not a trained predictor. Treat it as a way to rank attention, not as a forecast.